SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: SAREPTA THERAPEUTICS INC, SAREPTA THERAPEUTICS, INC., Sarepta Therapeutics, Inc., SAREPTA THERAPEUTICS, INC.
Client-Reported Lobbying Expenses
$8.4M
64 filings
Firm Income Reported for This Client
$145K
Not substituted for client expenses
Contract Awards
$150.9M
9 awards
SEC Insider
$343.0M
1,399 transactions
Summary
SAREPTA THERAPEUTICS, INC. (SRPT) is an organization. Its political footprint includes $8.4 million in client-reported lobbying expenses, $145K in lobbying-firm income reported for this client, $150.9 million in government contracts. Lobbying activity focuses on Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code, Science/Technology. Their largest government contract source is Department of Defense at $150.9 million. Political activity spans from 2008 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 22% YoY
2025: $1.2M (complete years)
Insider Trading
63 insiders
SEC filings: SEC EDGAR
Activity data: Senate LDA · USAspending.gov · SEC EDGAR